Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/z2...ermal_drug ) has announced the addition of the "Transdermal Drug Patches to 2018 Products, Indications, Markets and Forecasts" report to their offering.
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2018.
Highlights
- Analyzes and evaluates prescription skin patch products and assesses risks and market potential
- Analyzes patch designs, technologies and patch development issues
- Provides assessments of transdermal drug patch products in two dozen key market segments
- Provides market data and forecasts to 2018
- Profiles patch manufacturers, their product development activities and strategies
Key Topics Covered
Executive Summary
The Market Opportunity
- Transdermal Drug Delivery Dynamics
- Demand Drivers
- Competitive Landscape
- Factors Limiting Growth
- Pharmacokinetics & Dosage Forms
- Patch Manufacturing Dynamics
- Patch Manufacturing Company Profiles
Product Analysis - FDA-Approved Drugs Delivered via Transdermal Patches
- Alkaloids
- Androgens
- Antidepressants
- Antiemetics
- Antispasmodics
- CNS Stimulants
- Cholinesterase Inhibitors
- Dopamine Agonists
- Hormone Replacement
- Hypotensive Agents
- Local Anesthetics
- NSAIDs
- Opioid Analgesics
- Progestrins
- Trinitrates
Market Analysis - Transdermal Drug Patch Therapeutics
- ADHD
- Addiction
- Contraception
- Cardiovascular/Angina
- Depression
- Hormone Replacement Therapy
- Hypertension
- Motion Sickness
- Neurology
- Osteoporosis
- Pain Management
Market Factors
- Regulatory Issues
- IP and Expiring Patents
- Rx-to-OTC Switching
- Patient Compliance and Ease of Use
- Healthcare Economics
Profiles of Market Participants
For more information visit http://www.researchandmarkets.com/research/z2...ermal_drug
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery
